Pregnant or Breastfeeding Women : These medications are not currently cleared for use during pregnancy or while nursing
68 weeks): Highest dose (12 mg): 28.7% average weight loss (~71.2 lbs from ~248.5 lbs baseline
Some users notice a slight appetite return
CrossRef Bioinformatics Analysis Reveals the Role of DLGAP4 in the Development and Progression of Hepatocellular Carcinoma Feng Yang, Shoufeng Chang, Ruxia Li, Jing Wei, Hua Zhang, Qiqi Wang, Zhenjun Li, Yamei Dang Journal of Gastrointestinal Cancer .2025;[Epub] CrossRef Early screening for liver cancer must be performed Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang World Journal of Hepatology .2025;[Epub] CrossRef A novel peptide SMIM45-107aa promotes HCC progression via MTDH pathways and its anticancer peptide derivative Yan An, Xiangyang Shi, Wentao Huang, Mingyi Shang, Guang-Zhi Jin Journal of Translational Medicine .2025;[Epub] CrossRef Liver Transplantation for Hepatocellular Carcinoma: A Comprehensive Review Seok-Hwan Kim Convergence Hepatology .2025
